Literature DB >> 16432090

Predictors and prevalence of erectile dysfunction in a racially diverse population.

Christopher S Saigal1, Hunter Wessells, Jennifer Pace, Matt Schonlau, Timothy J Wilt.   

Abstract

BACKGROUND: To our knowledge, the burden of disease attributed to erectile dysfunction (ED) has not been adequately quantified across a complete spectrum of age and race using a global disease definition, as recommended by the National Institutes of Health consensus statement. To obtain a better understanding of the national estimates of prevalence and risk factors for ED, we analyzed data from the 2001-2002 National Health and Nutrition Examination Survey.
METHODS: The National Health and Nutrition Examination Survey collects data by household interview. The sample design is a stratified, multistage, probability sample of clusters of persons representing the civilian noninstitutionalized population. Data include medical histories in which specific queries are made regarding urological symptoms (including ED). These items were selected for analysis in 3566 men, 20 years and older.
RESULTS: In men 20 years and older, ED affected almost 1 in 5 respondents. Hispanic men were more likely to report ED (odds ratio [OR], 1.89), after controlling for other factors. The prevalence of ED increased dramatically with advanced age; 77.5% of men 75 years and older were affected. In addition, there were several modifiable risk factors that were independently associated with ED, including diabetes mellitus (OR, 2.69), obesity (OR, 1.60), current smoking (OR, 1.74), and hypertension (OR, 1.56).
CONCLUSIONS: The burden of ED on the US population is significant. Hispanic men had an elevated risk for ED, a finding that requires confirmation in prospective studies. Obesity, hypertension, smoking, and diabetes mellitus are significantly associated with ED risk. Mitigation of these risk factors may ameliorate the burden of ED.

Entities:  

Mesh:

Year:  2006        PMID: 16432090     DOI: 10.1001/archinte.166.2.207

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  71 in total

1.  Correlates of PDE5i use among subjects with erectile dysfunction in two population-based surveys.

Authors:  Thomas G Travison; Susan A Hall; William A Fisher; Andre B Araujo; Raymond C Rosen; John B McKinlay; Michael S Sand
Journal:  J Sex Med       Date:  2011-08-11       Impact factor: 3.802

Review 2.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

3.  Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis.

Authors:  Alexander W Pastuszak; Daniel A Hyman; Naveen Yadav; Guilherme Godoy; Larry I Lipshultz; Andre B Araujo; Mohit Khera
Journal:  J Sex Med       Date:  2015-03-02       Impact factor: 3.802

4.  Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Carol L Link; John B McKinlay
Journal:  Eur Urol       Date:  2007-03-16       Impact factor: 20.096

5.  Comparing the effects of meal replacements with reduced-fat diet on weight, sexual and endothelial function, testosterone and quality of life in obese Asian men.

Authors:  J Khoo; P-S Ling; J Tan; A Teo; H-L Ng; R Y-T Chen; T-L Tay; E Tan; M Cheong
Journal:  Int J Impot Res       Date:  2013-11-07       Impact factor: 2.896

Review 6.  Urological aspects of the metabolic syndrome.

Authors:  Jan Hammarsten; Ralph Peeker
Journal:  Nat Rev Urol       Date:  2011-08-02       Impact factor: 14.432

7.  Metabolic syndrome and urologic diseases.

Authors:  Ilya Gorbachinsky; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

8.  Association of Sleep Disordered Breathing with Erectile Dysfunction in Community Dwelling Older Men.

Authors:  Shahab Bozorgmehri; Howard A Fink; Neeta Parimi; Benjamin Canales; Kristine E Ensrud; Sonia Ancoli-Israel; Muna Canales
Journal:  J Urol       Date:  2016-09-30       Impact factor: 7.450

9.  A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.

Authors:  Brant A Inman; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Ajay Nehra; Michael M Lieber; Véronique L Roger; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

Review 10.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.